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a b s t r a c t   
The importance of RNA evidence is growing with new developments in RNA profiling methods and pur-
poses. As forensic samples often can be of small quantity, extraction methods with high yields of both DNA 
and RNA are desirable. In order to identify the optimal DNA/RNA co-extraction workflow for forensic 
samples, we evaluated the performance of three frequently-used methods, two new approaches for DNA/ 
RNA co-extraction and a manual phenol/chloroform RNA-only extraction method on blood and saliva 
samples. Based on a comprehensive analysis of the RNA and DNA quantities, as well as the STR genotyping 
and mRNA profiling results, we conclude that the two frequently-used co-extraction methods, combining 
commercially available DNA and RNA extraction kits, achieved the best performance. However, not any 
combination of commercially available DNA and RNA extraction kits works well and extensive optimization 
is necessary, as seen in the poor results of the two new approaches. 
© 2021 The Author(s). Published by Elsevier B.V. 
CC_BY_4.0   
1. Introduction 
With the rapid development of transcriptome analysis methods, 
the importance of RNA evidence has been recognized over the last 
decades and an increasing number of studies have shown the po-
tential of RNA profiling for forensic applications. RNA markers can be 
applied to achieve different purposes, such as body fluid identifica-
tion [1–4], organ tissue inference [5,6], estimating the age of a stain 
(time since deposition TsD) [7–9] and estimating the age of the stain 
donor [10,11]. So far, the most advanced field of application is the 
identification of body fluids using mRNA profiling, with conventional 
RT-PCR/CE methods [12–16], or up-to-date massively parallel se-
quencing (MPS) approaches [17–19]. However, due to the easily 
degrading nature of RNA molecules, successful RNA profiling usually 
requires the RNA extracts to have relatively high quantity and 
quality. Since forensic samples are often low-template and degraded, 
an effective DNA/RNA co-extraction method with satisfactory DNA/ 
RNA yields and integrity is of great value in practical use. 
There are already some commercial DNA/RNA co-extraction kits 
available, but they were not specifically developed for low-template 
samples. Hence, some alternative co-extraction methods aimed for 
criminal casework samples were proposed by several forensic la-
boratories [16,20,21]. However, only a few comparative studies had 
evaluated the performance of different RNA-only extraction methods 
or DNA/RNA co-extraction methods for forensic applications. Grab-
muller et al. [22] compared the performance of five commonly used 
RNA extraction methods, including some commercially available kits 
on dried blood, liquid saliva, semen and buccal mucosa samples. The 
different methods exhibited considerable variance concerning RNA 
and DNA yields, RNA quality and expression levels, and STR profiling 
success. They concluded that there was no ‘best’ method to satisfy all 
demands for co-analysis of RNA and DNA since each method has 
specific merits and flaws. Loureiro et al. [23] compared two DNA/ 
RNA co-extraction methods on semen samples, a commercial kit that 
uses a spin mini column methodology, and a quick, simple nucleic 
acid isopropanol precipitation based protocol. They found that the 
manual protocol performed worse, probably due to contaminant 
carryover that inhibits PCR. Bamberg et al. compared four different 
DNA/RNA co-extraction and re-extraction methods [15]. Best results 
were achieved with an automated re-extraction method. In brief, 
DNA was extracted with the Maxwell® FSC DNA IQ™ Casework Kit 
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(Promega). From the residue samples, RNA was re-extracted with the 
Maxwell® 16 RSC miRNA Tissue Kit (Promega). In a recent colla-
borative exercise, some self-optimized DNA/RNA co-extraction pro-
cedures have been established and applied by several forensic 
laboratories [24]. 
The aim of this study was to identify optimal DNA/RNA co-ex-
traction methods for forensic samples from three frequently-used 
methods that have already been applied by several forensic labora-
tories and two new approaches. We have chosen two co-extraction 
methods previously described by the Netherlands Forensic Institute 
(NFI, E1) and the Institute of Environmental Science and Research 
(ESR, E2) [16,21], as well as the AllPrep DNA/RNA Mini kit (Qiagen, 
E3). In addition, we tested two in-house approaches: Casework di-
rect kit followed by ReliaPrep™ RNA Cell Miniprep System (E4) and 
ReliaPrep™ RNA Cell Miniprep System followed by QIAamp DNA 
Mini Kit (E5). The RNA profiling performance was assessed and 
compared to the results of a manual phenol/chloroform RNA-only 
extraction method (E6) [25], which from our experience provides 
best RNA yields. In addition, we evaluated the RNA and DNA quan-
tities, and the STR genotyping performance. 
2. Methods 
The experiments were performed by two laboratories, Oslo 
University Hospital (Laboratory A) and the Zurich Institute of 
Forensic Medicine (Laboratory B). 
2.1. Sample preparation 
Human biological samples were collected at each laboratory from 
three unrelated healthy volunteers after receiving informed con-
sents, respectively. The sampling was performed in agreement with 
the local ethics regulations (Norway) and approved by the local 
ethics commission’s declaration of no objection (KEK-No. 24–2015, 
Switzerland). Peripheral blood was collected from finger pricks, 
saliva was collected by spitting. Subsequently, 2 µL and 20 µL of 
blood/saliva was pipetted onto swabs and dried at room temperature 
for at least 12 h. At Laboratory A the tips of the swab were cut with 
sterile scissors and placed in extraction tubes. The blood tips were 
stored at room temperature until the extraction procedure, while 
saliva tips were stored at 4°C. At Laboratory B the swabs were stored 
at room temperature until further processing. 
2.2. Extraction methods 
In total, six extraction methods were tested. Methods E1, E2, E3 
and E4 were evaluated by Laboratory A, and methods E1, E3, E5 and 
E6 were evaluated by Laboratory B. An overview on the applied 
methods is depicted in Fig. 1. One duplicate of 2 µL and 20 µL from 
each body fluid and each participant was analyzed, summing up to a 
total of 12 samples per extraction method. Negative controls were 
also tested. DNA extracts were stored at −20 °C and RNA extracts 
were stored at −80 °C until further processing. 
2.2.1. Extraction method E1: QIAamp DNA Mini Kit (Qiagen) and 
mirVana™ miRNA Isolation Kit (ThermoFisher) 
Co-extraction of RNA and DNA was performed as described by 
Lindenbergh et al. [16], with small alterations as suggested by the 
NFI (personal communication): Initially, samples were incubated 
with the mirVana Lysis/Bindig Buffer at 85 °C for 10 min at 750 rpm 
and cooled down. Proteinase K was added, followed by incubation at 
56 °C for 2 h. Absolute ethanol (112.5 µL, 1/4 vol Lysis/Binding buffer) 
was added for separating the fractions. Then, 48 µL miRNA homo-
genate was added to the flow through before further RNA purifica-
tion and addition of 132 µL nuclease free water as the first step of the 
RNA purification. The final elution volumes were 60 µL for RNA and 
100/40 µL (Laboratory A/B) for DNA, respectively. 
2.2.2. Extraction method E2: DNA IQ™ System and ReliaPrep™ RNA Cell 
Miniprep System (both from Promega) 
Samples were processed as described previously [21] according 
to the DNA IQ™ System—Small Sample Casework Protocol, with 
preprocessing using Lysis Buffer. Lysis Buffer (250 µL) was added to 
the samples and incubated at 70 °C for 30 min. Supernatant con-
taining RNA was removed after the first incubation on the magnetic 
stand, and transferred into a new tube for further purification. Lysis 
Buffer (100 µL) was added to the DNA fraction and the samples were 
removed from the magnetic stand and stored at 4 °C until further 
processing. RNA purification was performed as described in the 
manufacturer’s protocol, with 84 µL Isopropanol added to the lysate 
(250 µL). The RNA elution volume was 30 µL. The DNA samples were 
retrieved from storage and quickly vortexed, before placing back on 
the magnetic stand. Further purification was performed according to 
the protocol with a DNA elution volume of 100 µL. 
2.2.3. Extraction method E3: AllPrep™ DNA/RNA Mini kit (Qiagen) 
Initially, samples were lysed with RTL buffer (350 µL) and in-
cubated at 56 °C for 1 h. Lysates were then transferred into new 
tubes with QIAshredder spin-columns to get rid of the cotton. 
Further DNA/RNA co-extraction was performed according to the 
manufacturer’s instruction. The elution volumes for RNA and DNA 
were 30 µL and 100 µL in Laboratory A, and 30 and 40 µL in 
Laboratory B, respectively. 
2.2.4. Extraction method E4: Casework Direct Kit and ReliaPrep™ RNA 
Cell Miniprep System (both from Promega) 
This new protocol was tested, as the Casework direct kit is the in- 
house DNA extraction method in Laboratory A, therefore, an RNA 
extraction method that could be combined with the in-house 
method would be favorable. The swabs were transferred to a spin 
basket and 200 µL Casework Direct Solution was added, followed by 
incubation at 70 °C for 30 min, shaking was applied for the last 30 s. 
The samples were centrifuged at maximum speed for 5 min and the 
spin baskets were then removed and discarded. There is no further 
purification of DNA in the casework direct protocol. The sample was 
separated into 2 tubes, 100 µL for RNA and 100 µL for DNA. 
Isopropanol (34 µL) was added to the 100 µL RNA-lysate and the 
134 µL were transferred to ReliaPrep minicolumns for further pur-
ification according to the manufacture’s instruction. The RNA was 
eluted in 30 µL nuclease free water. 
2.2.5. Extraction method E5: ReliaPrep™ RNA Cell Miniprep System 
(Promega) followed by QIAamp DNA Mini Kit (Qiagen) 
Initially, samples were lysed with BL + TG buffer (250 µL) and 
incubated at 56 °C for 1 h. Lysates were then mixed with isopropanol 
(85 µL) and transferred onto ReliaPrep minicolumns. After cen-
trifugation, RNA extraction was performed according to the 
ReliaPrep protocol. The liquid flow-through was used to extract DNA 
with the QIAamp DNA Mini Kit. The elution volumes were 30 µL and 
40 µL for RNA and DNA, respectively. 
2.2.6. Extraction method E6: manual phenol/chloroform RNA extraction 
method 
RNA extraction with phenol/chloroform was performed as pre-
viously described by Juusola and Ballantyne [26] with a minor 
modification. Initially, samples were lysed with denaturing solution 
(500 µL) and incubated at 56 °C for 1 h. Lysates were then transferred 
into new tubes with QIAshredder spin-columns to get rid of the 
cotton. The elution volume for RNA was 20 µL. 
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2.3. DNA analysis 
In Laboratory A, DNA samples were quantified with the 
Quantifiler™ Trio DNA Quantification Kit and the 7500 Real-Time 
PCR System (ThermoFisher), according to the manufacturer’s re-
commendations. DNA samples were amplified (methods E1, E2 and 
E3) with the PowerPlex ESX17 Fast System kit (Promega) as re-
commended in the manufacturer’s protocol (0.5 ng template, 25 µL 
reaction volume and 30 amplification cycles). DNA samples from the 
casework direct method (extraction method E4) were amplified with 
addition of the Amp Solution (Promega, 2.5 µL for each sample) and 
PowerPlex ESX17 Fast on the Veriti™ 96-Well Thermal Cycler 
(ThermoFisher). Samples were injected on the 3500xl Genetic 
Analyzer (ThermoFisher) at 1.2 kV for 24 s. The results were analyzed 
using the GeneMapper ID-X Software V1.6 (ThermoFisher). 
In Laboratory B, DNA samples were quantified with the 
QuantiFluor® dsDNA System on the Quantus™ Fluorometer 
(Promega), according to the manufacturer’s recommendations. DNA 
was amplified with the AmpFLSTR™ NGM SElect™ PCR 
Amplification Kit (ThermoFisher) according to the manufacturer’s 
protocol (0.4 ng template, 25 µL reaction volume and 30 amplifica-
tion cycles). Samples were injected on the 3130xl Genetic Analyzer 
at 1.2 kV for 18 s. The results were analyzed using the GeneMapper 
ID-X Software v1.4 (ThermoFisher). 
2.4. RNA analysis 
DNase treatment was performed with the TURBO™ DNase kit 
(ThermoFisher) according to the manufacturer’s protocol. RNA was 
quantified using the QuantiFluor® RNA System on a Quantus™ 
Fluorometer (Promega) with the low standard according to the 
manufactures recommendations. 5 µL (Laboratory A) or 2 µL 
(Laboratory B) of the RNA extract was added to the working solution. 
Reverse Transcription was performed using the SuperScript® IV 
First-Strand cDNA Synthesis kit (Laboratory A) and the SuperScript® 
III Reverse Transcriptase (Laboratory B) (both from ThermoFisher), 
respectively. 
For comparison of the results, an in-house RNA 12plex for body 
fluid identification was used with 2.5 µL input, on a Veriti™ 96-Well 
Thermal Cycler or GeneAmp® PCR System 9700 (both from 
ThermoFisher), in Laboratory A and B, respectively. The RNA 12plex 
includes 12 mRNA markers, 2 human mRNA markers per body fluid 
(blood, saliva, semen, vaginal secretion, menstrual blood) and 2 
bacterial RNA markers (Lcris, Lgas) for the identification of vaginal 
secretion (Fig. 2). However, only the saliva markers (HTN3, MUC7) 
and the blood markers (HBA, ALAS2) are relevant here. The RNA 
12plex was provided by Laboratory B for all experiments to ensure 
comparability of results. 
Post PCR purification was performed with the Performa DTR Gel 
Filtration Cartridge (EdgeBio) for all samples analyzed in Laboratory 
A. Product separation was performed on the Genetic Analyzers 
3500xl (Laboratory A) or 3130xl (Laboratory B) (both from 
ThermoFisher), with 1 µL template and 10 s injection at 3 kV, 60 °C 
(Laboratory A) or 1 µL template and 10 s injection at 1.2 kV, 60 °C 
(Laboratory B). 
3. Results 
3.1. DNA results 
DNA quantity of the samples from Laboratory A ranged from 0.81 
to 946 ng (mean 121), while DNA quantity of the samples from 
Laboratory B ranged from 2.0 to 190 ng (mean 23.5). The average 
DNA quantity differed among extraction methods (Fig. 3). For La-
boratory A, the lowest average DNA quantity was from method E3 
(54.8 ng), while the highest average was from method E1 (252 ng). 
For Laboratory B, the lowest average quantity was observed from 
method E5 (14.1 ng), while the highest average quantity came from 
Fig. 1. Schematic representation of the DNA/RNA co-extraction and following analysis procedures.  
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method E1 (35.9 ng) (Fig. 3). Subsequent DNA genotyping analysis 
showed satisfactory results, full DNA profiles of good quality were 
achieved from all extraction methods, except for method E5. 
3.2. RNA results 
3.2.1. RNA yield 
For Laboratory A, the measured RNA quantity ranged from 2.64 to 
180 ng (mean 26.0). For Laboratory B, the measured RNA quantity 
ranged from 10.2 to 483 ng (mean 155). The average quantity dif-
fered among laboratories and methods (Fig. 4). For both laboratories, 
the lowest average quantity was from method E3 (6.62 ng for La-
boratory A and 19 ng for Laboratory B), while the highest average 
was from method E1 (50.8 ng for Laboratory A and 336 ng for La-
boratory B). No quantitation results exist for the samples extracted 
by method E4, due to the need for a re-run of the RT-PCR and 
therefore no sufficient volume for quantitation was available. 
3.2.2. mRNA profiling 
The Genetic Analyser 3500xl used by Laboratory A has a different 
sensitivity and maximum peak height than the Genetic Analyser 
3130xl used by Laboratory B. For a better comparison between the 
labs, the peak heights for samples analyzed by Laboratory A where 
divided by 3 following previously published recommendations [27]. 
For Laboratory A, all expected peaks corresponding to the correct 
body fluids were observed from the analysis results of samples ex-
tracted by methods E1–E3, while weaker signals were observed from 
method E4 (Fig. 5). The average peak height differed among the top 3 
methods, with the highest observed average from method E2 fol-
lowed by methods E3 and E1. For Laboratory B, more robust mRNA 
profiling results (more mRNA markers with higher peak heights) 
were obtained from methods E1 and E6, irrespective of sample type 
and input amount. The highest peak was from MUC7, which was 
observed in a 20 µL saliva sample extracted with method E1. The 
poorest mRNA profiling result was observed from method E3, with 
the lowest number of successfully detected mRNA markers. The 
measured RNA quantities did not correlate well with the observed 
peak heights, in general or when considering the 4 mRNA markers 
separately (Fig. 6). However, the general trend is visible. 
4. Discussion 
Within this study, we identified expedient DNA/RNA co-extrac-
tion methods among three frequently-used and two new approaches 
in a forensic setting. We tested five different DNA/RNA co-extraction 
methods and compared the RNA performance to a manual phenol/ 
chloroform RNA-only extraction method. We evaluated the RNA and 
DNA quantities, as well as STR and RNA profiling performance. 
Methods E1–E3 and E5 use a waste product during RNA- or DNA- 
extraction to recover the DNA or RNA, respectively. In method E4 the 
lysate is divided into 2 aliquots, for DNA and RNA isolation, which is 
disadvantageous for optimal DNA and RNA yields. 
All extraction methods achieved good DNA genotyping results 
based on the RFU values of detected peaks, except for method E5. 
Method E1 showed significantly better results than all other 
methods, when only the DNA quantity is considered. A difference in 
DNA yield between Laboratory A and B was observed, which is most 
likely due to the different quantitation methods, fluorescence vs 
quantitative PCR. The measured quantities are not absolutely accu-
rate for low-template samples, but still a good measure to calibrate 
the downstream analysis and differences between labs and methods 
are expected. In addition, the different elution volumes could have 
an impact on the final DNA yield. It is possible that with the higher 
elution volume used by laboratory A, more DNA could be recovered 
from the column membranes. A good DNA genotyping result from a 
DNA/RNA co-extraction is of high importance in casework, where 
Fig. 2. In-house RNA 12plex, including 2 markers per body fluid (blood (red), saliva (blue), semen (yellow), vaginal secretion (green), menstrual blood (pink), plus 2 microbial 
vaginal markers (green)). The amplicon lengths are depicted, the fluorescent dyes are FAM, VIC, NED, from top to bottom. *HTN1 is an isoform that is also recognized with the 
HTN3 primer pair. (For interpretation of the references to color in this figure, the reader is referred to the online version of this article.) 
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sample material is limited, and there is often no opportunity for new 
sample collection, e.g. from swabs. A method that provides equal or 
better DNA results than existing DNA extraction methods is essential 
if co-extraction should be prioritized in a case. 
Complete RNA profiles (all expected peaks detected) were ob-
tained for all samples extracted with methods E1–E3 from 
Laboratory A. However, some peaks were not detected (allele drop- 
out) in RNA profiling results from Laboratory B, especially for the 
2 µL saliva samples. This might be simply due to the Genetic 
Analyzer 3500xl being more sensitive than 3130xl. When comparing 
the methods in parallel, extraction method E1 showed the best DNA/ 
RNA concentration and profiling results. In addition, method E6 also 
performed well judged by the RNA yield and peak height, but this 
method was designed for RNA extraction only, thus could not be the 
first choice when DNA genotyping is also required. Extraction 
method E4 was the fastest and the easiest method to perform. 
Unfortunately, the RNA results were of low quality compared to the 
other methods. This method has not been tested for RNA extraction 
previously and it is possible that the extraction buffer conditions are 
not optimal for RNA isolation. Extraction method E5 was a self- 
created combination that was not optimized, partly explaining the 
unsuccessful DNA genotyping results in some samples. Even though, 
the performance of the ReliaPrep RNA Cell Miniprep System in the 
RNA extraction part was good. 
The RNA quantity did not correlate well with the final RNA 
profiling result when considering the RFU values of detected mar-
kers. However, the general trend was visible. This is probably be-
cause the RNA quantitation method is not human specific and 
especially for saliva samples the presence of bacterial RNA could 
influence the quantitation results. Another explanation could be that 
the expression of different markers varied in the transcriptome of 
different individuals. Besides, inhibition could play a role in down-
stream analyses, e.g. from the DNase inactivation reagent in the 
TURBO™ DNase treatment. 
If only considering time and labor, extraction method E3 comes 
best out of the tests. However, the quantitation results for both RNA 
and DNA showed an unsatisfactory performance for this method. 
Extraction methods E1 and E2 are quite similar for several pipetting 
steps. Considering time of procedure and co-extraction performance, 
these 2 methods were both practicable when dealing with forensic 
samples. 
There are also some limitations in our current study. We had tested 
blood and saliva samples, in a reasonable number of samples. However, 
this is still a limited selection of body fluids and small sample size, 
considering the huge variation in the DNA and RNA results. We also did 
not test any automated protocols, which would be advantageous for 
high throughput analyses. Though, some of the herein manually per-
formed kit based methods could easily be transferred on a robot. Since 
the performance of RNA profiling was only evaluated based on mRNA 
markers, we cannot say whether the optimal co-extraction methods 
identified in this study are also suitable for small RNA isolation. Due to 
the shorter length, additional enrichment or purification steps are 
sometimes suggested by commercial RNA extraction kits (e.g. 
mirVana™ miRNA Isolation Kit) to obtain a better recovery rate of small 
RNA molecules. Therefore, assessment of these co-extraction methods 
with other previously proposed small RNA markers for body fluid 
identification would be worth investigating by further studies focusing 
on small RNA profiling. 
Fig. 3. The measured DNA quantity (ng) in the samples containing 2 µL or 20 µL of blood (red) or saliva (blue), extracted by Laboratory A with methods E1–E4 and Laboratory B 
with methods E1, E3 and E5, method E6 was an RNA-only extraction method and thus is not exhibited here. (For interpretation of the references to color in this figure, the reader is 
referred to the online version of this article.) 
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Fig. 4. The measured RNA quantity (ng) in the samples containing 2 µL or 20 µL of blood (red) or saliva (blue), extracted by Laboratory A with methods E1–E3 and Laboratory B 
with methods E1, E3, E5 and E6. (No quantitation results exist for the samples extracted by method E4). (For interpretation of the references to color in this figure, the reader is 
referred to the online version of this article.) 
Fig. 5. Boxplot showing the RFU values for the blood (ALAS2 and HBA) and saliva (HTN3 and MUC7) mRNA markers detected in samples extracted with methods E1–E4 by 
Laboratory A and methods E1, E3, E5 and E6 by Laboratory B. 
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5. Conclusion 
We evaluated the performance of five different DNA/RNA co-ex-
traction methods and compared the RNA profiling results to a manual 
phenol/chloroform RNA-only extraction method on blood and saliva 
samples. Variable DNA/RNA quantities were observed among the tested 
methods. Even with low input blood/saliva samples (2 µL), successful 
DNA genotyping was achieved with all methods, except for method E5. 
The RNA profiling results showed that methods E1 and E2, which are 
two modified and optimized co-extraction methods combining com-
mercially available DNA and RNA extraction kits, achieved the best 
performance in this study. However, the suboptimal performance of 
methods E4 and E5 show that not any combination of commercially 
available DNA and RNA extraction kits works well and extensive opti-
mization is necessary. In short, our findings could provide instructive 
information for future studies regarding the selection of DNA/RNA co- 
extraction methods. 
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